| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)
|
Argilés, Guillem
|
|
|
177 |
C |
p. 154-163
|
artikel
|
| 2 |
CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients
|
Isebia, Khrystany T.
|
|
|
177 |
C |
p. 33-44
|
artikel
|
| 3 |
Clinicopathologic characteristics and prognostic impact of atypical EGFR mutations in completely resected lung adenocarcinoma
|
She, Yunlang
|
|
|
177 |
C |
p. 53-62
|
artikel
|
| 4 |
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis
|
Viscardi, Giuseppe
|
|
|
177 |
C |
p. 175-185
|
artikel
|
| 5 |
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
|
Nowatzke, Joseph
|
|
|
177 |
C |
p. 197-205
|
artikel
|
| 6 |
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]
|
Rimini, Margherita
|
|
|
177 |
C |
p. 206-207
|
artikel
|
| 7 |
Erratum to ‘Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma’ [Eur J Cancer 170 (2022) 209-235]
|
Budde, Axel
|
|
|
177 |
C |
p. 208-209
|
artikel
|
| 8 |
European regulatory strategy for supporting childhood cancer therapy developments
|
Karres, Dominik
|
|
|
177 |
C |
p. 25-29
|
artikel
|
| 9 |
High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy
|
Dercle, Laurent
|
|
|
177 |
C |
p. 80-93
|
artikel
|
| 10 |
Immune checkpoint inhibitor-associated myocarditis and coronary artery disease: There may be more than meets the eye!
|
Maria, Alexandre T.J.
|
|
|
177 |
C |
p. 194-196
|
artikel
|
| 11 |
Impact of radiation therapy on fatigue at 1 year in breast cancer survivors in the prospective multicentre CANcer TOxicity cohort
|
Ghannam, Youssef
|
|
|
177 |
C |
p. 143-153
|
artikel
|
| 12 |
Intelligent multi-modal shear wave elastography to reduce unnecessary biopsies in breast cancer diagnosis (INSPiRED 002): a retrospective, international, multicentre analysis
|
Pfob, André
|
|
|
177 |
C |
p. 1-14
|
artikel
|
| 13 |
Letter re: “Systematic review and non-inferiority meta-analysis of randomised phase II/III trials on S-1-based therapy versus 5-fluorouracil- or capecitabine-based therapy in the treatment of patients with metastatic colorectal cancer”
|
Chang, Chen
|
|
|
177 |
C |
p. 30-32
|
artikel
|
| 14 |
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial
|
Apolo, Andrea B.
|
|
|
177 |
C |
p. 63-71
|
artikel
|
| 15 |
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors
|
Pearson, Andrew DJ.
|
|
|
177 |
C |
p. 120-142
|
artikel
|
| 16 |
Patterns of care for relapsed oesophageal cancer after initial curative trimodality therapy: Long-term follow-up of the SAKK 75/08 trial
|
Panje, Cédric
|
|
|
177 |
C |
p. 186-193
|
artikel
|
| 17 |
Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1
|
Huang, Min
|
|
|
177 |
C |
p. 45-52
|
artikel
|
| 18 |
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial
|
Véron, Marie
|
|
|
177 |
C |
p. 103-111
|
artikel
|
| 19 |
The impact of the SARS-COV-2 pandemic on the quality of breast cancer care in EUSOMA-certified breast centres
|
van Dam, Peter
|
|
|
177 |
C |
p. 72-79
|
artikel
|
| 20 |
The oncological multidimensional prognostic index is a promising decision-making tool: A real-world analysis in older patients with metastatic colorectal cancer
|
Procaccio, Letizia
|
|
|
177 |
C |
p. 112-119
|
artikel
|
| 21 |
The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020
|
Cabasag, Citadel J.
|
|
|
177 |
C |
p. 15-24
|
artikel
|
| 22 |
Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer
|
Lakbir, Soufyan
|
|
|
177 |
C |
p. 94-102
|
artikel
|
| 23 |
Tumour infiltrating B cells discriminate checkpoint blockade-induced responses
|
Valpione, Sara
|
|
|
177 |
C |
p. 164-174
|
artikel
|
Tijdschrift beschrijving